![Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/a2942442-98b3-4a59-963b-97985b17a85d/emmm202113968-abs-0001-m.jpg)
Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity | EMBO Molecular Medicine
![Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group | BMC Neurology | Full Text Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-015-0412-3/MediaObjects/12883_2015_412_Fig1_HTML.gif)
Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group | BMC Neurology | Full Text
![Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder](https://www.mdpi.com/biomolecules/biomolecules-10-01339/article_deploy/html/images/biomolecules-10-01339-g001.png)
Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
![Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620302896-fx1.jpg)
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect
![Pompe Disease Therapeutic Market Share Expected to Grow at a CAGR of 3.5% by 2027 | Growing Demand Drives the market in Healthcare | Medgadget Pompe Disease Therapeutic Market Share Expected to Grow at a CAGR of 3.5% by 2027 | Growing Demand Drives the market in Healthcare | Medgadget](https://www.medgadget.com/wp-content/uploads/2021/09/pompe-disease-therapeutic-market.jpg)
Pompe Disease Therapeutic Market Share Expected to Grow at a CAGR of 3.5% by 2027 | Growing Demand Drives the market in Healthcare | Medgadget
![PDF] Pompe disease diagnosis and management guideline ACMG Work Group on Management of Pompe Disease : | Semantic Scholar PDF] Pompe disease diagnosis and management guideline ACMG Work Group on Management of Pompe Disease : | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a5598bfc7e40ca4d19b3aa571ea0dcd7ce8d0311/3-Table1-1.png)
PDF] Pompe disease diagnosis and management guideline ACMG Work Group on Management of Pompe Disease : | Semantic Scholar
![Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease | EMBO Molecular Medicine Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/b36ef59a-f869-41a9-95ba-5962a21021e4/emmm202114434-abs-0001-m.jpg)